Determination of 25‐Hydroxyvitamin D 3 in Rat Brain by Derivatization‐Assisted LC/ESI‐MS/MS
Biomedical Chromatography · 2025
DOI: 10.1002/bmc.70119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Toma Shibuya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Brain Chemistry, Calcifediol, Spectrometry, Mass, Electrospray Ionization. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Recent studies have suggested that vitamin D deficiency may have relations with various neuropsychiatric diseases as well as bone diseases. However, the concentrations of vitamin D metabolites in the brain and the relationship between their brain and serum concentrations remain poorly understood. To answer these questions, we developed and validated an LC/ESI‐MS/MS method for quantifying 25‐hydroxyvitamin D 3 [25(OH)D 3 ], an established marker for assessing vitamin D sufficiency/deficiency, in the rat brain and compared the brain concentrations with the serum concentrations. To enhance the assay sensitivity and specificity, the 25(OH)D 3 was derivatized with 4‐[4‐(1‐pipelidinyl)phenyl]‐1,2,4‐triazoline‐3,5‐dione (PIPTAD) after purification of the brain sample by a two‐step solid‐phase extraction. A good linearity was obtained within the range of 20–1000 pg/g tissue, and the intra‐assay and interassay precision and accuracy were acceptable. In normal rats ( n = 6), the brain 25(OH)D 3 concentrations ranged from 128 to 175 pg/g tissue, which were extremely low (approximately 1/100) compared to the serum concentrations. The bile duct ligation caused the decreased serum 25(OH)D 3 level, which produced the subsequent decreased brain 25(OH)D 3 level (44–79 pg/g, n = 6). These results strongly suggested that the serum 25(OH)D 3 concentration has a significant effect on its brain level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.
- Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Fukuyama, Japan.
ORCID-Profile: Tatsuya Higashi
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Shibuya, T., Shishikura, F., Yoshida, N., Ogawa, S., & Higashi, T. (2025). Determination of 25‐Hydroxyvitamin D 3 in Rat Brain by Derivatization‐Assisted LC/ESI‐MS/MS. Biomedical Chromatography. https://doi.org/10.1002/bmc.70119
Vancouver
Shibuya T, Shishikura F, Yoshida N, Ogawa S, Higashi T. Determination of 25‐Hydroxyvitamin D 3 in Rat Brain by Derivatization‐Assisted LC/ESI‐MS/MS. Biomedical Chromatography. 2025. doi:10.1002/bmc.70119
BibTeX
@article{Shibuya2025,
author = {Shibuya, Toma and Shishikura, Fuwari and Yoshida, Natsuki and Ogawa, Shoujiro and Higashi, Tatsuya},
title = {Determination of 25‐Hydroxyvitamin D 3 in Rat Brain by Derivatization‐Assisted LC/ESI‐MS/MS},
journal = {Biomedical Chromatography},
year = {2025},
doi = {10.1002/bmc.70119}
}
EUVIMED